Cited by 2,056Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisOccupational and environmental lung diseasesTransplantation: Methods and Outcomes

The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.

Idiopathic Pulmonary Fibrosis

Lederer, David J., Martinez, Fernando J.·2018·New England Journal of Medicine

DOI 10.1056/nejmra1705751

Open this paper in CoChat — free account

Abstract

Idiopathic pulmonary fibrosis appears to be increasing in incidence. It requires early recognition and intervention with supportive care and pharmacologic agents to forestall its progression. Lung transplantation may be curative.

Integrity signals

Registry

Crossref · 10.1056/nejmra1705751

Cites

98 of 98 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J.-F., Flaherty, K. R., Lasky, J. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2009-040gl · Cited by 7,186
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Richeldi, L., du Bois, R. M., Raghu, G., Azuma, A., Brown, K. K., Costabel, U., Cottin, V., Flaherty, K. R., Hansell, D. M., Inoue, Y., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402584 · Cited by 4,654
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
King, T. E., Bradford, W. Z., Castro-Bernardini, S., Fagan, E. A., Glaspole, I., Glassberg, M. K., Gorina, E., Hopkins, P. M., Kardatzke, D., Lancaster, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402582 · Cited by 3,975
Self-citation
Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2013) · Annals of Internal Medicine · doi:10.7326/m13-2771 · Cited by 2,642
Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017.
MacMahon, H., Naidich, D. P., Goo, J. M., Lee, K. S., Leung, A. N. C., Mayo, J. R., Mehta, A. C., Ohno, Y., Powell, C. A., Prokop, M., et al. (2017) · Radiology · doi:10.1148/radiol.2017161659 · Cited by 2,491
An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis: An Update of the 2011 Clinical Practice Guideline
Raghu, G., Rochwerg, B., Zhang, Y., Garcia, C. A. C., Azuma, A., Behr, J., Brozek, J. L., Collard, H. R., Cunningham, W., Homma, S., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201506-1063st · Cited by 1,916
Prednisone, Azathioprine, and N -Acetylcysteine for Pulmonary Fibrosis
The Idiopathic Pulmonary Fibrosis Clinical Research Network (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113354 · Cited by 1,654
Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report
Collard, H. R., Ryerson, C. J., Corte, T. J., Jenkins, G., Kondoh, Y., Lederer, D. J., Lee, J. S., Maher, T. M., Wells, A. U., Antoniou, K. M., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201604-0801ci · Cited by 1,444
Self-citation
Telomerase Mutations in Families with Idiopathic Pulmonary Fibrosis
Armanios, M. Y., Chen, J. J.-L., Cogan, J. D., Alder, J. K., Ingersoll, R. G., Markin, C., Lawson, W. E., Xie, M., Vulto, I., Phillips, J. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066157 · Cited by 1,357
A consensus document for the selection of lung transplant candidates: 2014–an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation
Weill, D., Benden, C., Corris, P. A., Dark, J. H., Davis, R. D., Keshavjee, S., Lederer, D. J., Mulligan, M. J., Patterson, G. A., Singer, L. G., et al. (2015) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2014.06.014 · Cited by 1,329
Self-citation
A Common MUC5B Promoter Polymorphism and Pulmonary Fibrosis
Seibold, M. A., Wise, A. L., Speer, M. C., Steele, M. P., Brown, K. M., Loyd, J. E., Fingerlin, T. E., Zhang, W., Guðmundsson, G., Groshong, S. D., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1013660 · Cited by 1,235
Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span
Misharin, A. V., Morales-Nebreda, L., Reyfman, P. A., Cuda, C. M., Walter, J. M., McQuattie-Pimentel, A. C., Chen, C.-I., Anekalla, K. R., Joshi, N., Williams, K. J. N., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20162152 · Cited by 1,133
Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper
Lynch, D. A., Sverzellati, N., Travis, W. D., Brown, K. K., Colby, T. V., Galvin, J. R., Goldin, J. G., Hansell, D. M., Inoue, Y., Johkoh, T., et al. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30433-2 · Cited by 1,030
Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review
Hutchinson, J., Fogarty, A., Hubbard, R., & McKeever, T. M. (2015) · European Respiratory Journal · doi:10.1183/09031936.00185114 · Cited by 913
Adult-onset pulmonary fibrosis caused by mutations in telomerase
Tsakiri, K. D., Cronkhite, J. T., Kuan, P. J., Xing, C., Raghu, G., Weissler, J. C., Rosenblatt, R. L., Shay, J. W., & Garcia, C. K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701009104 · Cited by 894
Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis
Fingerlin, T. E., Murphy, E., Zhang, W., Peljto, A. L., Brown, K. K., Steele, M. P., Loyd, J. E., Cosgrove, G. P., Lynch, D., Groshong, S., et al. (2013) · Nature Genetics · doi:10.1038/ng.2609 · Cited by 809
Short telomeres are a risk factor for idiopathic pulmonary fibrosis
Alder, J. K., Chen, J. J.-L., Lancaster, L., Danoff, S., Su, S.-C., Cogan, J. D., Vulto, I., Xie, M., Qi, X., Tuder, R. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804280105 · Cited by 805
Muc5b is required for airway defence
Roy, M. G., Livraghi-Butrico, A., Fletcher, A. A., McElwee, M. M., Evans, S. E., Boerner, R. M., Alexander, S. N., Bellinghausen, L. K., Song, A. S., Petrova, Y. M., et al. (2014) · Nature · doi:10.1038/nature12807 · Cited by 764
Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11
Raghu, G., Chen, S.-Y., Yeh, W.-S., Maroni, B., Li, Q., Lee, Y.-C., & Collard, H. R. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70101-8 · Cited by 716
Idiopathic Interstitial Pneumonia
Flaherty, K. R., King, T. E., Raghu, G., Lynch, J. P., Colby, T. V., Travis, W. D., Gross, B. H., Kazerooni, E. A., Toews, G. B., Long, Q., et al. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200402-147oc · Cited by 672
Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study
Noth, I., Zhang, Y., Ma, S., Flores, C., Barber, M., Huang, Y., Broderick, S. M., Wade, M. S., Hysi, P. G., Scuirba, J., et al. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70045-6 · Cited by 622
MMP1 and MMP7 as Potential Peripheral Blood Biomarkers in Idiopathic Pulmonary Fibrosis
Rosas, I. O., Richards, T. J., Konishi, K., Zhang, Y., Gibson, K., Lokshin, A. E., Lindell, K. O., Cisneros, J., MacDonald, S. D., Pardo, A., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050093 · Cited by 582
Increased Prevalence of Gastroesophageal Reflux in Patients with Idiopathic Pulmonary Fibrosis
Tobin, R. W., Pope, C. E., Pellegrini, C. A., Emond, M. J., Sillery, J. K., & Raghu, G. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.6.9804105 · Cited by 568
The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis
Molyneaux, P. L., Cox, M. J., Willis-Owen, S. A. G., Mallia, P., Russell, K. E., Russell, A.-M., Murphy, E., Johnston, S. L., Schwartz, D. A., Wells, A. U., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201403-0541oc · Cited by 567
Treatment of Idiopathic Pulmonary Fibrosis With Ambrisentan: A Parallel, Randomized Trial
Raghu, G., Behr, J., Brown, K. K., Egan, J. J., Kawut, S. M., Flaherty, K. R., Martinez, F. J., Nathan, S. D., Wells, A. U., Collard, H. R., et al. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-9-201305070-00003 · Cited by 553
Self-citation
Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial
King, T. E., Albera, C., Bradford, W. Z., Costabel, U., Hormel, P., Lancaster, L., Noble, P. W., Sahn, S. A., Szwarcberg, J., Thomeer, M., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60551-1 · Cited by 531
Randomized Trial of Acetylcysteine in Idiopathic Pulmonary Fibrosis
The Idiopathic Pulmonary Fibrosis Clinical Research Network (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401739 · Cited by 506
P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study
Abdulqawi, R., Dockry, R., Holt, K. J., Layton, G. R., McCarthy, B. G., Ford, A. P. D. W., & Smith, J. A. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61255-1 · Cited by 488
Association Between Interstitial Lung Abnormalities and All-Cause Mortality
Putman, R. K., Hatabu, H., Araki, T., Guðmundsson, G., Gao, W. D., Nishino, M., Okajima, Y., Dupuis, J., Latourelle, J. C., Cho, M. H., et al. (2016) · JAMA · doi:10.1001/jama.2016.0518 · Cited by 480
Revealing the Pathogenic and Aging-related Mechanisms of the Enigmatic Idiopathic Pulmonary Fibrosis. An Integral Model
Selman, M., & Pardo, A. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201312-2221pp · Cited by 472
Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review
Raghu, G., Amatto, V. C., Behr, J., & Stowasser, S. (2015) · European Respiratory Journal · doi:10.1183/13993003.02316-2014 · Cited by 470
A Placebo-Controlled Randomized Trial of Warfarin in Idiopathic Pulmonary Fibrosis
Noth, I., Anstrom, K. J., Calvert, S. B., de Andrade, J., Flaherty, K. R., Glazer, C., Kaner, R. J., & Olman, M. A. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201202-0314oc · Cited by 463
MUC5B Promoter Polymorphism and Interstitial Lung Abnormalities
Hunninghake, G. M., Hatabu, H., Okajima, Y., Gao, W. D., Dupuis, J., Latourelle, J. C., Nishino, M., Araki, T., Zazueta, O. E., Kurugol, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1216076 · Cited by 463
Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS® trials
Richeldi, L., Cottin, V., du Bois, R. M., Selman, M., Kimura, T., Bailes, Z., Schlenker-Herceg, R., Stowasser, S., & Brown, K. K. (2016) · Respiratory Medicine · doi:10.1016/j.rmed.2016.02.001 · Cited by 463
Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study
Walsh, S. L. F., Wells, A. U., Desai, S. R., Poletti, V. E., Piciucchi, S., Dubini, A., Nunès, H., Valeyre, D., Brillet, P., Kambouchner, M., et al. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)30033-9 · Cited by 461
Gastroesophageal Reflux Therapy Is Associated with Longer Survival in Patients with Idiopathic Pulmonary Fibrosis
Lee, J. S., Ryu, J. H., Elicker, B. M., Lydell, C. P., Jones, K. D., Wolters, P. J., King, T. E., & Collard, H. R. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201101-0138oc · Cited by 435
Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study
Han, M. K., Zhou, Y., Murray, S., Tayob, N., Noth, I., Lama, V. N., Moore, B. B., White, E. S., Flaherty, K. R., Hu, B., et al. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70069-4 · Cited by 419
Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials
Lee, J. S., Collard, H. R., Anstrom, K. J., Martínez, F. J., Noth, I., Roberts, R., Yow, E. S., & Raghu, G. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70105-x · Cited by 415
Occupational and Environmental Risk Factors for Idiopathic Pulmonary Fibrosis: A Multicenter Case-Control Study
Baumgartner, K. B., Samet, J. M., Coultas, D., Stidley, C. A., Hunt, W. C., Colby, T. V., Waldron, J. A., & Centers, C. (2000) · American Journal of Epidemiology · doi:10.1093/aje/152.4.307 · Cited by 374
Incidence and prevalence of idiopathic pulmonary fibrosis in US adults 18–64 years old
Raghu, G., Chen, S., Hou, Q., Yeh, W., & Collard, H. R. (2016) · European Respiratory Journal · doi:10.1183/13993003.01653-2015 · Cited by 348
TOLLIP , MUC5B , and the Response to N -Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis
Oldham, J. M., Ma, S.-F., Martinez, F. J., Anstrom, K. J., Raghu, G., Schwartz, D. A., Valenzi, E., Witt, L., Lee, C., Vij, R., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201505-1010oc · Cited by 341
Bronchoscopic Lung Cryobiopsy Increases Diagnostic Confidence in the Multidisciplinary Diagnosis of Idiopathic Pulmonary Fibrosis
Tomassetti, S., Wells, A. U., Costabel, U., Cavazza, A., Colby, T. V., Rossi, G., Sverzellati, N., Carloni, A., Carretta, E., Buccioli, M., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201504-0711oc · Cited by 339
Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis
Nathan, S. D., Albera, C., Bradford, W. Z., Costabel, U., Glaspole, I., Glassberg, M. K., Kardatzke, D. R., Daigl, M., Kirchgaessler, K.-U., Lancaster, L. H., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)30326-5 · Cited by 335
Self-citation
Herpesvirus DNA Is Consistently Detected in Lungs of Patients with Idiopathic Pulmonary Fibrosis
Tang, Y., Johnson, J. E., Browning, P. J., Cruz-Gervis, R. A., Davis, A., Graham, B. S., Brigham, K. L., Oates, J. A., Loyd, J. E., & Stecenko, A. A. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.6.2633-2640.2003 · Cited by 310
Nintedanib with Add-on Pirfenidone in Idiopathic Pulmonary Fibrosis. Results of the INJOURNEY Trial
Vancheri, C., Kreuter, M., Richeldi, L., Ryerson, C. J., Valeyre, D., Grutters, J. C., Wiebe, S., Stansen, W., Quaresma, M., Stowasser, S., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201706-1301oc · Cited by 305
Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study
Allen, R. J., Porte, J., Braybrooke, R., Flores, C., Fingerlin, T. E., Oldham, J. M., Guillen-Guio, B., Ma, S.-F., Okamoto, T., John, A. E., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30387-9 · Cited by 297
The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK
Jeune, I. L., Gribbin, J., West, J., Smith, C., Cullinan, P., & Hubbard, R. (2007) · Respiratory Medicine · doi:10.1016/j.rmed.2007.07.012 · Cited by 295
Clarifying Stem-Cell Therapy’s Benefits and Risks
Marks, P. W., Witten, C. M., & Califf, R. M. (2016) · New England Journal of Medicine · doi:10.1056/nejmp1613723 · Cited by 294
Efficacy of Nintedanib in Idiopathic Pulmonary Fibrosis across Prespecified Subgroups in INPULSIS
Costabel, U., Inoue, Y., Richeldi, L., Collard, H. R., Tschoepe, I., Stowasser, S., & Azuma, A. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201503-0562oc · Cited by 280
The evidence of benefits of exercise training in interstitial lung disease: a randomised controlled trial
Dowman, L., McDonald, C. F., Hill, C. J., Lee, A. L., Barker, K., Boote, C., Glaspole, I., Goh, N. S. L., Southcott, A. M., Burge, A. T., et al. (2017) · Thorax · doi:10.1136/thoraxjnl-2016-208638 · Cited by 279
The need for randomization in the study of intended effects
Miettinen, O. S. (1983) · Statistics in Medicine · doi:10.1002/sim.4780020222 · Cited by 277
Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume
Kolb, M. R. J., Richeldi, L., Behr, J., Maher, T. M., Tang, W., Stowasser, S., Hallmann, C., & du Bois, R. M. (2016) · Thorax · doi:10.1136/thoraxjnl-2016-208710 · Cited by 242
Host–Microbial Interactions in Idiopathic Pulmonary Fibrosis
Molyneaux, P. L., Willis‐Owen, S. A. G., Cox, M. J., James, P. L., Cowman, S. A., Loebinger, M. R., Blanchard, A. D., Edwards, L. M., Stock, C. J. W., Daccord, C., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201607-1408oc · Cited by 222
Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysis
Kreuter, M., Wuyts, W. A., Renzoni, E. A., Koschel, D., Maher, T. M., Kolb, M. R. J., Weycker, D. A., Spagnolo, P., Kirchgaessler, K.-U., Herth, F. J. F., et al. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)00067-9 · Cited by 219
Diagnostic Yield and Complications of Transbronchial Lung Cryobiopsy for Interstitial Lung Disease. A Systematic Review and Metaanalysis
Johannson, K. A., Marcoux, V. S., Ronksley, P. E., & Ryerson, C. J. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201606-461sr · Cited by 216
Increasing Global Mortality from Idiopathic Pulmonary Fibrosis in the Twenty-First Century
Hutchinson, J. P., McKeever, T. M., Fogarty, A., Navaratnam, V. V., & Hubbard, R. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201404-145oc · Cited by 214
Pirfenidone Reduces Respiratory-related Hospitalizations in Idiopathic Pulmonary Fibrosis
Ley, B., Swigris, J. J., Day, B.-M., Stauffer, J. L., Raimundo, K., Chou, W., & Collard, H. R. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201701-0091oc · Cited by 212
Thalidomide for the Treatment of Cough in Idiopathic Pulmonary Fibrosis
Horton, M. R., Santopietro, V., Mathew, L., Horton, K. M., Polito, A. J., Liu, M. C., Danoff, S. K., & Lechtzin, N. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-6-201209180-00003 · Cited by 206
Drug Treatment of Idiopathic Pulmonary Fibrosis
Canestaro, W. J., Forrester, S. H., Raghu, G., Ho, L. A., & Devine, B. E. (2016) · CHEST Journal · doi:10.1016/j.chest.2015.11.013 · Cited by 188
Nintedanib and Pirfenidone. New Antifibrotic Treatments Indicated for Idiopathic Pulmonary Fibrosis Offer Hopes and Raises Questions
Raghu, G., & Selman, M. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201411-2044ed · Cited by 184
Plasma surfactant protein-D, matrix metalloproteinase-7, and osteopontin index distinguishes idiopathic pulmonary fibrosis from other idiopathic interstitial pneumonias
White, E. S., Xia, M., Murray, S., Dyal, R., Flaherty, C. M., Flaherty, K. R., Moore, B. B., Cheng, L., Doyle, T. J., Villalba, J., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201505-0862oc · Cited by 180
Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function
Albera, C., Costabel, U., Fagan, E., Glassberg, M. K., Gorina, E., LANCASTER, L. H., Lederer, D. J., Nathan, S. D., Spirig, D., & Swigris, J. J. (2016) · European Respiratory Journal · doi:10.1183/13993003.01966-2015 · Cited by 169
Self-citation
High attenuation areas on chest computed tomography in community-dwelling adults: the MESA study
Podolanczuk, A. J., Oelsner, E. C., Barr, R. G., Hoffman, E. A., Armstrong, H. F., Austin, J. H. M., Basner, R. C., Bartels, M. N., Christie, J. D., Enright, P., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.00129-2016 · Cited by 167
Self-citation
Palliative Care and Location of Death in Decedents With Idiopathic Pulmonary Fibrosis
Lindell, K. O., Liang, Z., Hoffman, L. A., Rosenzweig, M. Q., Saul, M. I., Pilewski, J. M., Gibson, K. F., & Kaminski, N. (2014) · CHEST Journal · doi:10.1378/chest.14-1127 · Cited by 166
OPTN/SRTR 2016 annual data report: lung
Valapour, M., Lehr, C. J., Skeans, M. A., Smith, J. M., Carrico, R., Uccellini, K., Lehman, R., Robinson, A., Israni, A. K., Snyder, J. J., et al. (2018) · American Journal of Transplantation · doi:10.1111/ajt.14562 · Cited by 163
Idiopathic Pulmonary Fibrosis in United States Automated Claims: Incidence, Prevalence, and Algorithm Validation
Esposito, D. B., Lanes, S., Donneyong, M. M., Holick, C. N., Lasky, J. A., Lederer, D. J., Nathan, S. D., O’Quinn, S., Parker, J. M., & Tran, T. N. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201504-0818oc · Cited by 153
Self-citation
Microbes Are Associated with Host Innate Immune Response in Idiopathic Pulmonary Fibrosis
Huang, Y., Ma, S.-F., Espindola, M. S., Vij, R., Oldham, J. M., Huffnagle, G. B., Erb-Downward, J. R., Flaherty, K. R., Moore, B. B., White, E. S., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201607-1525oc · Cited by 142
Classification of usual interstitial pneumonia in patients with interstitial lung disease: assessment of a machine learning approach using high-dimensional transcriptional data
Kim, S. Y., Diggans, J., Pankratz, D., Huang, J., Pagan, M., Sindy, N., Tom, E., Anderson, J. D., Choi, Y., Lynch, D. A., et al. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00140-x · Cited by 137
Therapeutic targets in idiopathic pulmonary fibrosis
Kolb, M. R. J., Bonella, F., & Wollin, L. (2017) · Respiratory Medicine · doi:10.1016/j.rmed.2017.07.062 · Cited by 134
The use of pretest probability increases the value of high-resolution CT in diagnosing usual interstitial pneumonia
Brownell, R., Moua, T., Henry, T. S., Elicker, B. M., White, D. B., Vittinghoff, E., Jones, K. D., Urisman, A., Aravena, C., Johannson, K. A., et al. (2017) · Thorax · doi:10.1136/thoraxjnl-2016-209671 · Cited by 128
Air pollution and subclinical interstitial lung disease: the Multi-Ethnic Study of Atherosclerosis (MESA) air–lung study
Sack, C. S., Vedal, S., Sheppard, L. A., Raghu, G., Barr, R. G., Podolanczuk, A. J., Doney, B. C., Hoffman, E. A., Gassett, A. J., Stukovsky, K. H., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00559-2017 · Cited by 126
Self-citation
A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial
Birring, S. S., Wijsenbeek, M. S., Agrawal, S., van den Berg, J. W., Stone, H., Maher, T. M., Tutuncu, A., & Morice, A. H. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30310-7 · Cited by 123
Diagnostic yield and postoperative mortality associated with surgical lung biopsy for evaluation of interstitial lung diseases: A systematic review and meta-analysis
Han, Q., Luo, Q., Xie, J., Wu, L., Liao, L.-Y., Zhang, X., & Chen, R. (2015) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.12.057 · Cited by 117
MUC5B Promoter Variant rs35705950 Affects MUC5B Expression in the Distal Airways in Idiopathic Pulmonary Fibrosis
Nakano, Y., Yang, I. V., Walts, A. D., Watson, A. M., Helling, B. A., Fletcher, A. A., Lara, A., Schwarz, M. I., Evans, C. M., & Schwartz, D. A. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201509-1872le · Cited by 113
Effect of Emphysema Extent on Serial Lung Function in Patients with Idiopathic Pulmonary Fibrosis
Cottin, V., Hansell, D. M., Sverzellati, N., Weycker, D. A., Antoniou, K. M., Atwood, M., Oster, G., Kirchgaessler, K.-U., Collard, H. R., & Wells, A. U. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201612-2492oc · Cited by 112
Effect of Lung Transplantation on Health-Related Quality of Life in the Era of the Lung Allocation Score: A U.S. Prospective Cohort Study
Singer, J. P., Katz, P., Soong, A., Shrestha, P., Huang, D., Ho, J., Mindo, M., Greenland, J. R., Hays, S. R., Golden, J. A., et al. (2016) · American Journal of Transplantation · doi:10.1111/ajt.14081 · Cited by 109
High Complication Rate after Introduction of Transbronchial Cryobiopsy into Clinical Practice at an Academic Medical Center
DiBardino, D. M., Haas, A. R., Lanfranco, A. R., Litzky, L. A., Sterman, D. H., & Bessich, J. L. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201610-829oc · Cited by 108
Treatment of idiopathic pulmonary fibrosis: a network meta-analysis
Rochwerg, B., Neupane, B., Zhang, Y., Garcia, C. C., Raghu, G., Richeldi, L., Brozek, J., Beyene, J., & Schünemann, H. (2016) · BMC Medicine · doi:10.1186/s12916-016-0558-x · Cited by 101
Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case–cohort study
Walsh, S. L. F., Maher, T. M., Kolb, M. R. J., Poletti, V. E., Nusser, R., Richeldi, L., Vancheri, C., WILSHER, M. L., Antoniou, K. M., Behr, J., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00936-2017 · Cited by 100
Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis
van Manen, M. J. G., Birring, S. S., Vancheri, C., Vindigni, V., Renzoni, E. A., Russell, A., Wapenaar, M., Cottin, V., & Wijsenbeek, M. S. (2017) · European Respiratory Journal · doi:10.1183/13993003.01157-2017 · Cited by 99
Recombinant human pentraxin-2 therapy in patients with idiopathic pulmonary fibrosis: safety, pharmacokinetics and exploratory efficacy
van den Blink, B., Dillingh, M. R., Ginns, L. C., Morrison, L. D., Moerland, M., Wijsenbeek, M. S., Trehu, E., Bartholmai, B. J., & Burggraaf, J. (2016) · European Respiratory Journal · doi:10.1183/13993003.00850-2015 · Cited by 98
Usual Interstitial Pneumonia Can Be Detected in Transbronchial Biopsies Using Machine Learning
Pankratz, D. G., Choi, Y., Imtiaz, U., Fedorowicz, G. M., Anderson, J. D., Colby, T. V., Myers, J. L., Lynch, D. A., Brown, K. K., Flaherty, K. R., et al. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201612-947oc · Cited by 96
The Peripheral Blood Transcriptome Identifies the Presence and Extent of Disease in Idiopathic Pulmonary Fibrosis
Yang, I. V., Luna, L. G., Cotter, J., Talbert, J. L., Leach, S. M., Kidd, R., Turner, J., Kummer, N., Kervitsky, D. J., Brown, K. K., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037708 · Cited by 94
Disease-Specific Survival Benefit of Lung Transplantation in Adults: A National Cohort Study
Titman, A., Rogers, C. A., Bonser, R. S., Banner, N. R., & Sharples, L. D. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02613.x · Cited by 90
High-Attenuation Areas on Chest Computed Tomography and Clinical Respiratory Outcomes in Community-Dwelling Adults
Podolanczuk, A. J., Oelsner, E. C., Barr, R. G., Bernstein, E. J., Hoffman, E. A., Easthausen, I. J., Stukovsky, K. H., RoyChoudhury, A., Michos, E. D., Raghu, G., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201703-0555oc · Cited by 83
Self-citation
The Increasing Secondary Care Burden of Idiopathic Pulmonary Fibrosis
Navaratnam, V. V., Fogarty, A., Glendening, R., McKeever, T. M., & Hubbard, R. (2013) · CHEST Journal · doi:10.1378/chest.12-0803 · Cited by 74
An Official American Thoracic Society/American College of Chest Physicians Policy Statement
Wiener, R. S., Ouellette, D. R., Diamond, E., Fan, V. S., MAURER, J. R., Mularski, R. A., Peters, J. I., & Halpern, S. D. (2014) · CHEST Journal · doi:10.1378/chest.14-0670 · Cited by 74
Greater endurance capacity and improved dyspnoea with acute oxygen supplementation in idiopathic pulmonary fibrosis patients without resting hypoxaemia
Dowman, L., Mcdonald, C., Bozinovski, S., Vlahos, R., Gillies, R., Pouniotis, D., Hill, C., Goh, N., & Holland, A. E. (2017) · Respirology (Carlton South. Print) · doi:10.1111/resp.13002 · Cited by 73
Obstructive Sleep Apnea and Subclinical Interstitial Lung Disease in the Multi-Ethnic Study of Atherosclerosis (MESA)
Kim, J. S., Podolanczuk, A. J., Borker, P. V., Kawut, S. M., Raghu, G., Kaufman, J. D., Stukovsky, K. H., Hoffman, E. A., Barr, R. G., Gottlieb, D. J., et al. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201701-091oc · Cited by 66
Self-citation
Timing of onset of symptoms in people with idiopathic pulmonary fibrosis
Hewson, T., McKeever, T. M., Gibson, J., Navaratnam, V. V., Hubbard, R., & Hutchinson, J. P. (2017) · Thorax · doi:10.1136/thoraxjnl-2017-210177 · Cited by 66
Predictors of idiopathic pulmonary fibrosis in absence of radiologic honeycombing: A cross sectional analysis in ILD patients undergoing lung tissue sampling
Salisbury, M. L., Xia, M., Murray, S., Bartholmai, B. J., Kazerooni, E. A., Meldrum, C. A., Martínez, F. J., & Flaherty, K. R. (2016) · Respiratory Medicine · doi:10.1016/j.rmed.2016.07.016 · Cited by 52
Microbiome in lung explants of idiopathic pulmonary fibrosis: a case–control study in patients with end-stage fibrosis
Kitsios, G. D., Rojas, M. M., Kass, D. J., Fitch, A. C., Sembrat, J., Qin, S., Veraldi, K. L., Gibson, K. F., Lindell, K. O., Pilewski, J. M., et al. (2017) · Thorax · doi:10.1136/thoraxjnl-2017-210537 · Cited by 50
Interstitial Lung Disease: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases
Rosas, I. O., Dellaripa, P. F., Lederer, D. J., Khanna, D., Young, L. R., & Martínez, F. J. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201312-429ld · Cited by 46
Self-citation
Venous thromboembolism in people with idiopathic pulmonary fibrosis: a population-based study
Dalleywater, W. J., Powell, H. A., Fogarty, A., Hubbard, R., & Navaratnam, V. V. (2014) · European Respiratory Journal · doi:10.1183/09031936.00099614 · Cited by 36
The Lung Microbiome in Idiopathic Pulmonary Fibrosis. What Does It Mean and What Should We Do about It?
Morris, A., Gibson, K. F., & Collman, R. G. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201409-1626ed · Cited by 26
Cryobiopsy in the Diagnosis of Interstitial Lung Disease. A Step Forward or Back?
Patel, N. M., Borczuk, A., & Lederer, D. J. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201511-2313ed · Cited by 23
Self-citation
TD139, A Novel Inhaled Galectin-3 Inhibitor for The Treatment of Idiopathic Pulmonary Fibrosis (IPF). Results from The First in (IPF) Patients Study.
Hirani, N., Nicol, L. M., MacKinnon, A. C., Ford, P., Schambye, H. T., Pedersen, Nilsson, U., Leffler, H., Thomas, T., Knott, O., et al. (2016) · QJM · doi:10.1093/qjmed/hcw127.003 · Cited by 21
PRAISE, a randomized, placebo-controlled, double-blind Phase 2 clinical trial of pamrevlumab (FG-3019) in IPF patients
Gorina, E., Richeldi, L., Raghu, G., Pérez, E. R. F., Costabel, U., Albera, C., Lederer, D. J., Flaherty, K. R., Ettinger, N. A., Bercz, P. A., et al. (2017) · doi:10.1183/1393003.congress-2017.oa3400 · Cited by 19
Self-citation

Flagged first, then by citations

Research works printed but not linked: 2

Philp CJ, Siebeke I, Clements D, et al. ECM crosslinking enhances fibroblast growth and protects against matrix proteolysis in lung fibrosis. Am J Respir Cell Mol Biol 2017 October 20 (Epub ahead of print).29053339
Parker J, Sawtell R, Gagnon L, et al. PBI-4050 is safe and well tolerated and shows evidence of benefit in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2017;195:A7606-A7606. abstract.

Sorted by citations

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
Flaherty, K. R., Wells, A. U., Cottin, V., Devaraj, A., Walsh, S. L. F., Inoue, Y., Richeldi, L., Kolb, M., Tetzlaff, K., Stowasser, S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1908681 · Cited by 2,403
Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis
Adams, T. S., Schupp, J. C., Poli, S., Ayaub, E. A., Neumark, N., Ahangari, F., Chu, S. G., Raby, B. A., DeIuliis, G., Januszyk, M., et al. (2020) · Science Advances · doi:10.1126/sciadv.aba1983 · Cited by 1,420
Single-Cell Transcriptomic Analysis of Human Lung Provides Insights into the Pathobiology of Pulmonary Fibrosis
Reyfman, P. A., Walter, J. M., Joshi, N., Anekalla, K. R., McQuattie-Pimentel, A. C., Chiu, S., Fernandez, R., Akbarpour, M., Chen, C.-I., Ren, Z., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201712-2410oc · Cited by 1,203
New insights into TGF-β/Smad signaling in tissue fibrosis
Hu, H.-H., Chen, D., Wang, Y., Feng, Y., Cao, G., Vaziri, N. D., & Zhao, Y. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.07.008 · Cited by 1,205
Single-cell RNA sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis
Habermann, A. C., Gutierrez, A. J., Bui, L. T., Yahn, S. L., Winters, N. I., Calvi, C. L., Peter, L., Chung, M.-I., Taylor, C. J., Jetter, C., et al. (2020) · Science Advances · doi:10.1126/sciadv.aba1972 · Cited by 1,129

See all 2,056

Authors: Lederer, D. J., & Martinez, F. J.
Affiliations: Columbia University Irving Medical Center (US)
From the Departments of Medicine and Epidemiology, Columbia University Irving Medical Center (D.J.L.), and the Department of Medicine, Weill Cornell Medical Center (F.J.M.) — both in New York.
ORCID: Lederer, David J.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2018-05-10
Volume: 378
Issue: 19
Pages: 1811-1823
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmra1705751
OpenAlex: W2799479598
Cited by: 2,056
References: 98
Citations by year: 2026: 248 · 2025: 267 · 2024: 299 · 2023: 308 · 2022: 301 · 2021: 266 · 2020: 197 · 2019: 129 · 2018: 40
FWCI: 28.43
Type: journal article
Language: en
Open access: closed
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
Keywords: idiopathic pulmonary fibrosis, incidence, early recognition, supportive care, pharmacotherapy, disease progression, lung transplantation
MeSH terms: Diagnosis, Differential, Dyspnea, Enzyme Inhibitors, Humans, Indoles, Lung, Oxygen Inhalation Therapy, Prognosis, Pyridones, Risk Factors, Tomography, X-Ray Computed, Transforming Growth Factor beta, Idiopathic Pulmonary Fibrosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Idiopathic Pulmonary Fibrosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks